Anthrax vaccine oral - AVANT ImmunotherapeuticsAlternative Names: Oral anthrax vaccine - AVANT Immunotherapeutics
Latest Information Update: 20 Jun 2007
At a glance
- Originator AVANT Immunotherapeutics
- Class Anthrax vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Anthrax
Most Recent Events
- 03 May 2007 Discontinued - Preclinical for Anthrax in USA (PO)
- 24 Feb 2004 This vaccine is still in active development
- 29 Jul 2002 Preclinical trials in Anthrax in USA (PO)